cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Taysha Gene Therapies Inc
5 own
7 watching
Current Price
$1.16
$-0.07
(-5.69%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
47.76M
52-Week High
52-Week High
8.14
52-Week Low
52-Week Low
1.06
Average Volume
Average Volume
0.67M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization47.76M
icon52-Week High8.14
icon52-Week Low1.06
iconAverage Volume0.67M
iconDividend Yield--
iconP/E Ratio--
What does the Taysha Gene Therapies Inc do?
Taysha Gene Therapies, Inc.is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. We were founded in partnership with The University of Texas Southwestern Medical Center, or UT Southwestern, to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we are advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs at no cost. Taysha Gene Therapies, Inc.principal executive offices are located at 2280 Inwood Road, Dallas, Texas 75235 and our telephone number is (214) 612-0000. Our website address is www.tayshagtx.com
Read More
How much money does Taysha Gene Therapies Inc make?
News & Events about Taysha Gene Therapies Inc.
Zolmax
3days ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating) had its price objective decreased by Truist Financial from $15.00 to $4.00 in a report released on Wednesday, The Fly reports. Truist Financial currently has a buy rating on the stock. Several other analysts have also weighed in on the company. ...
PR Newswire
3 months ago
Thinking about buying stock in Taysha Gene Therapies, Nio, Traeger, Amprius Technologies, or Sellas Life Sciences? Thinking about buying stock in Taysha Gene Therapies, Nio, Traeger, Amprius Technologies, or Sellas Life Sciences? PR Newswire NEW YORK, Oct. 25, 2022 NEW YORK, Oct. 25, 2022...
Ticker Report
5 months ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating) had its price objective cut by research analysts at Chardan Capital from $34.00 to $32.00 in a research report issued on Friday, Marketbeat Ratings reports. The brokerage presently has a buy rating on the stock. Several other ...
Zolmax
7 months ago
Taysha Gene Therapies (NASDAQ:TSHA Get Rating) and Gamida Cell (NASDAQ:GMDA Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst ...
Globe Newswire
8 months ago
The Annual Stockholder Meeting on Friday, June 17, 2022 at 10 am ETDALLAS, June 13, 2022 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of ...
Frequently Asked Questions
Frequently Asked Questions
What is Taysha Gene Therapies Inc share price today?
plus_minus_icon
Can Indians buy Taysha Gene Therapies Inc shares?
plus_minus_icon
How can I buy Taysha Gene Therapies Inc shares from India?
plus_minus_icon
Can Fractional shares of Taysha Gene Therapies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Taysha Gene Therapies Inc stocks?
plus_minus_icon
What is today’s traded volume of Taysha Gene Therapies Inc?
plus_minus_icon
What is today’s market capitalisation of Taysha Gene Therapies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Taysha Gene Therapies Inc?
plus_minus_icon
What percentage is Taysha Gene Therapies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Taysha Gene Therapies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.16
$-0.07
(-5.69%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00